Cancer mRNA “vaccines” will be distributed to vital organs and cause severe heart damage

Earlier this year, Dr. Peter McCullough issued a stark warning about the mRNA cancer vaccines that are being trialled.  “Messenger RNA likes to go to the heart where it causes heart damage.  Almost every messenger RNA platform causes heart damage,” he said.

In July 2023, the UK government partnered with BioNTech to develop and trial personalised mRNA cancer vaccines, with the aim of providing access to these vaccines for up to 10,000 patients by 2030.  The first clinical trials for these personalised cancer vaccines began in the autumn of 2023, with the majority of patients being enrolled from 2026 onwards.

Oxford University Hospitals also launched an mRNA cancer vaccine trial for patients with head and neck cancers in December 2023.

Related: All mRNA injections, including cancer vaccines, may accelerate the development of cancer

In January 2024, Larry Ellison announced that the Stargate Project, a joint venture involving Oracle, OpenAI and SoftBank, aimed to develop a personalised cancer vaccine using artificial intelligence (“AI”) technology.  The vaccine will be developed using mRNA technology.

Related: Larry Ellison has created a media storm about his proposal for AI-generated mRNA cancer vaccines

While it may be possible that AI can develop a personalised cancer therapy, the problem is the mRNA technology.  During an interview with The Endtime Show in January,  American epidemiologist and cardiologist Dr. Peter McCullough explained why mRNA vaccines for cancer will do more harm than good.

“A messenger RNA vaccine can make a protein per individual strand of messenger RNA.,  So, even if you had a blend of them, you could make some different proteins but you can’t control how much of the protein is made and you can’t shut it off right now and you can’t control where it’s distributed in the body.  And right now, messenger RNA likes to go to the heart where it causes heart damage.  Almost every messenger RNA platform causes heart damage, so that’s going to be the Achilles heel of using messenger RNA technology,” he said.